BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 11510002)

  • 21. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies.
    Min KW; Seo IS; Pitha J
    Ultrastruct Pathol; 2005; 29(6):535-48. PubMed ID: 16316954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.
    Seidal T; Kindblom LG; Angervall L
    Appl Pathol; 1987; 5(4):201-19. PubMed ID: 3689591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular neurothekeoma: detailed characterization in a series of 133 cases.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Mar; 31(3):329-40. PubMed ID: 17325474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic features of pleomorphic hyalinizing angiectatic tumor of soft parts.
    Ke Q; Erbolat ; Zhang HY; Bu H; Li S; Shi DN; Yang GH; Chen HJ; Wei B
    Chin Med J (Engl); 2007 May; 120(10):876-81. PubMed ID: 17571460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
    Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
    Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process.
    Auerbach A; Fanburg-Smith JC; Wang G; Rushing EJ
    Am J Surg Pathol; 2009 Jul; 33(7):1016-24. PubMed ID: 19363438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary pulmonary rhabdomyosarcomas: a clinicopathologic and immunohistochemical study of three cases.
    Przygodzki RM; Moran CA; Suster S; Koss MN
    Mod Pathol; 1995 Aug; 8(6):658-61. PubMed ID: 8532701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
    Fanburg-Smith JC; Furlong MA; Childers EL
    Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous rhabdomyosarcoma: a clinicopathologic review of 11 cases.
    Marburger TB; Gardner JM; Prieto VG; Billings SD
    J Cutan Pathol; 2012 Nov; 39(11):987-95. PubMed ID: 22994900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyosarcoma. Morphologic, immunohistochemical, and DNA study.
    Gruchała A; Niezabitowski A; Wasilewska A; Sikora K; Ryś J; Szklarski W; Jaszcz A; Lackowska B; Herman K
    Gen Diagn Pathol; 1997 Feb; 142(3-4):175-84. PubMed ID: 9065581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
    Moosavi C; Jha P; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Oct; 11(5):313-9. PubMed ID: 17870015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas.
    Skalli O; Gabbiani G; Babaï F; Seemayer TA; Pizzolato G; Schürch W
    Am J Pathol; 1988 Mar; 130(3):515-31. PubMed ID: 3279794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital rhabdomyosarcoma. Immunohistochemical studies of seven cases.
    Sun XL; Zheng BH; Li B; Li LQ; Soejima K; Kanda M
    Chin Med J (Engl); 1990 Jun; 103(6):485-8. PubMed ID: 2119961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2008 Apr; 32(4):493-501. PubMed ID: 18223480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rhabdomyosarcoma: morphology and cellular differentiation].
    Schmidt D; Harms D; Reimann O; Treuner J
    Klin Padiatr; 1986; 198(3):202-7. PubMed ID: 3523025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
    Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
    Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histopathologic and immunohistochemical study of rhabdomyosarcoma].
    Lai RQ
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):184-6. PubMed ID: 2612328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma.
    Zhang HY; Yang GH; Chen HJ; Wei B; Ke Q; Guo H; Ye L; Bu H; Yang K; Zhang YH
    Chin Med J (Engl); 2005 Sep; 118(17):1451-61. PubMed ID: 16157048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagenous fibroma (desmoplastic fibroblastoma): a report of seven cases.
    Nielsen GP; O'Connell JX; Dickersin GR; Rosenberg AE
    Mod Pathol; 1996 Jul; 9(7):781-5. PubMed ID: 8832562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
    Yun K
    Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.